MGMT and glioblastoma: Age and extent of surgery were nonetheless identified by Gorlia et al. in the population of GBM patients who underwent partial or complete resection and were assigned to temozolomide and radiotherapy without the knowledge of the MGMT promoter methylation status (population 2 of the EORTC trial).